Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at ...

The Amsterdam UMC has sued Ronald Plasterk and the biotech firm CureVac for failing to credit the hospital and its scientist, ...

Amsterdam’s UMC teaching hospital is taking former Labour minister and PVV prime ministerial hopeful Ronald Plasterk to court ...

Shares in CureVac have plummeted after a German court ruled that a patent it holds on mRNA-based COVID-19 vaccines was invalid. The validity of the patent is at the heart of patent litigation ...

Moderna has been testing an mRNA candidate for influenza viruses like the H5 and H7 strains that are seen as pandemic threats ...

GSK has upgraded its longstanding alliance with CureVac on mRNA-based vaccines for respiratory infections, paying €400 million ($429 million) upfront for global rights to its influenza and COVID ...

While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.

In this review of RNA therapies, we paint an overview of what’s going on in a field that is addressing a number of diseases.

After hours: 7:45:06 p.m. EST ...